期刊文献+

江苏省常州市特药保障政策实施成效评估研究:以HER-2阳性乳腺癌为例 被引量:2

Research on the Evaluation of Special Drug Policy in Changzhou,Jiangsu:Taking HER-2 Positive Breast Cancer as the Example
原文传递
导出
摘要 以常州市为样本地区,以HER-2阳性乳腺癌病种为例,测算江苏省医疗保险特殊药品保障政策推出前后患者的医药费用负担,以"灾难性卫生支出"为指标来评估医疗保险特殊药品保障项目的实施成效。结果显示,该政策使患者经济负担大幅下降,发生灾难性卫生支出的概率显著降低;医保基金总支出的绝对值虽然在逐年上升,但基金支出年增长率与政策前相比却呈下降趋势,说明该政策的实施并未给基金带来大的冲击。 Selecting Changzhou as the sample region, it took the HER-2 positive breast cancer as example to calculate the medical burden of patients after the implementation of Jiangsu Province's special drug poliey. It evaluated the implementation effect of serious illness medicines project according to the "catastrophic health expenditure". The result showed that the policy could reduce the patients' financial burden and the probability of catastrophic health expenditure. Compared to the situation before the implementation of this policy, though the absolute value of total expenditure by medical insurance fund raised by years, the growth rate of expenditure decreased gradually, which showed that the policy did not cause a big shock to the medical insurance fund.
出处 《中国卫生经济》 北大核心 2017年第3期43-45,共3页 Chinese Health Economics
基金 国家自然科学基金面上项目(71273278) 2015年中国药科大学"华海药业研究生创新基金"项目
关键词 医疗保险特殊药品 医疗保障 灾难性卫生支出 江苏 special medicine in medical insurance health care insurance catastrophic health expenditure Jiangsu
  • 相关文献

参考文献5

二级参考文献41

  • 1徐旭卿,刘北斗,李群,何铁牛.浙江省耐药肺结核病人人口学特征及家庭疾病经济负担对照研究[J].中国防痨杂志,2004,26(6):332-335. 被引量:10
  • 2郭金玲,张亮,王宇明,孙亮,梁素英,李立,田庆丰,施学中.艾滋病对农村高发地区患者家庭经济影响的调查分析[J].中国卫生经济,2006,25(3):48-51. 被引量:23
  • 3王舒宏,刘兴柱,李士雪,袁长海,王金祥,杨宝金.疟疾病例经济负担分析[J].中国初级卫生保健,1996,10(9):33-35. 被引量:8
  • 4丛明华,田兴松,刘奇,李志伟.DNA微阵列在乳腺癌研究中的进展[J].中华外科杂志,2007,45(13):887-888. 被引量:4
  • 5Hortobagyi G N.Trastuzumab in the treatment of breast cancer[J].N Engl J Med,2005,353(16):1734-1736. 被引量:1
  • 6National Comprehensive Cancer Network.Breast cancer treatment guidelines 2006[M/OL].NCCN Guidelines&Clinical Resources[2010-02-25].http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. 被引量:1
  • 7Buzdar A U,Ibrahim N K,Francis D,et al.Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab,paclitaxel,and epirubicin chemotherapy:results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer[J].J Clin Oncol,2005,23(16):3676-3685. 被引量:1
  • 8Buzdar A U,Valero V,Ibrahim N K,et al.Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil,epirubicin,and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer:an update of the initial randomized study population and data of additional patients treated with the same regimen[J].Clin Cancer Res,2007,13(1):228-233. 被引量:1
  • 9陈立新,吴彦领.三门峡市结核病疾病经济负担调查[J].预防医学论坛,2007,13(10):869-871. 被引量:3
  • 10Islam M K,Gerdtham U G. The costs of maternal -newbornillneSvS and mortality. Moving towards universal coverage:issues in maternal -newborn health and poverty[R]. Geneva:World Health Organization, 2006. 被引量:1

共引文献49

同被引文献31

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部